Back to search

Article

Dapagliflozin promotes white adipose tissue browning though regulating angiogenesis in high fat induced obese mice

2023-06-12

Abstract excerpt

Browning of white adipose tissue (WAT) is become an appealing target for therapeutics in the treatment of obesity and related metabolic diseases. Dapagliflozin is widely used in the treatment of type 2 diabetes, and it is also found that the drug exhibits regulate systemic metabolism such as obesity, insulin resistance and hepatic steatosis. However, the precise role of dapagliflozin on WAT remodeling remains to b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d4c0d4a0-7a81-5d60-90e2-2d79de21d1b9
DOI
10.21203/rs.3.rs-3010926/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dapagliflozin promotes white adipose tissue browning though regulating angiogenesis in high fat induced obese miceDOI 10.21203/rs.3.rs-3010926/v1
Select a neighboring publication to make it the new centre.